STRAUMANN HOLDING AG-REG (QS51.DE) Stock Fundamental Analysis
FRA:QS51 - Deutsche Boerse Ag - CH1175448666 - Common Stock - Currency: EUR
Taking everything into account, QS51 scores 7 out of 10 in our fundamental rating. QS51 was compared to 58 industry peers in the Health Care Equipment & Supplies industry. QS51 has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QS51 is quite expensive at the moment. It does show a decent growth rate. This makes QS51 very considerable for quality investing!
1. Profitability
1.1 Basic Checks
QS51 had positive earnings in the past year.
In the past year QS51 had a positive cash flow from operations.
QS51 had positive earnings in each of the past 5 years.
QS51 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QS51 has a Return On Assets of 10.73%. This is amongst the best in the industry. QS51 outperforms 87.93% of its industry peers.
QS51 has a Return On Equity of 19.03%. This is amongst the best in the industry. QS51 outperforms 84.48% of its industry peers.
Looking at the Return On Invested Capital, with a value of 19.95%, QS51 belongs to the top of the industry, outperforming 98.28% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for QS51 is significantly above the industry average of 8.41%.
The last Return On Invested Capital (19.95%) for QS51 is above the 3 year average (19.58%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.73% | ||
| ROE | 19.03% | ||
| ROIC | 19.95% |
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
1.3 Margins
With an excellent Profit Margin value of 15.51%, QS51 belongs to the best of the industry, outperforming 84.48% of the companies in the same industry.
In the last couple of years the Profit Margin of QS51 has declined.
The Operating Margin of QS51 (25.97%) is better than 94.83% of its industry peers.
In the last couple of years the Operating Margin of QS51 has remained more or less at the same level.
QS51 has a Gross Margin of 71.40%. This is in the better half of the industry: QS51 outperforms 77.59% of its industry peers.
In the last couple of years the Gross Margin of QS51 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.97% | ||
| PM (TTM) | 15.51% | ||
| GM | 71.4% |
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), QS51 is creating value.
Compared to 1 year ago, QS51 has about the same amount of shares outstanding.
QS51 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, QS51 has an improved debt to assets ratio.
2.2 Solvency
QS51 has an Altman-Z score of 9.10. This indicates that QS51 is financially healthy and has little risk of bankruptcy at the moment.
QS51 has a Altman-Z score of 9.10. This is amongst the best in the industry. QS51 outperforms 96.55% of its industry peers.
QS51 has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
QS51 has a Debt to FCF ratio of 1.49. This is amongst the best in the industry. QS51 outperforms 93.10% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that QS51 is not too dependend on debt financing.
QS51's Debt to Equity ratio of 0.11 is amongst the best of the industry. QS51 outperforms 81.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | 9.1 |
ROIC/WACC4.05
WACC4.92%
2.3 Liquidity
QS51 has a Current Ratio of 1.61. This is a normal value and indicates that QS51 is financially healthy and should not expect problems in meeting its short term obligations.
QS51 has a Current ratio (1.61) which is comparable to the rest of the industry.
QS51 has a Quick Ratio of 1.15. This is a normal value and indicates that QS51 is financially healthy and should not expect problems in meeting its short term obligations.
QS51 has a Quick ratio (1.15) which is comparable to the rest of the industry.
The current and quick ratio evaluation for QS51 is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
The earnings per share for QS51 have decreased by -0.72% in the last year.
Measured over the past 5 years, QS51 shows a small growth in Earnings Per Share. The EPS has been growing by 5.26% on average per year.
The Revenue has grown by 9.98% in the past year. This is quite good.
QS51 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.42% yearly.
EPS 1Y (TTM)-0.72%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-26.32%
Revenue 1Y (TTM)9.98%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%8.65%
3.2 Future
QS51 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.31% yearly.
Based on estimates for the next years, QS51 will show a quite strong growth in Revenue. The Revenue will grow by 9.77% on average per year.
EPS Next Y31.67%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
EPS Next 5Y19.31%
Revenue Next Year8.48%
Revenue Next 2Y9.47%
Revenue Next 3Y9.7%
Revenue Next 5Y9.77%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 39.90, the valuation of QS51 can be described as expensive.
QS51's Price/Earnings is on the same level as the industry average.
QS51's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.17.
QS51 is valuated quite expensively with a Price/Forward Earnings ratio of 30.31.
QS51's Price/Forward Earnings is on the same level as the industry average.
QS51's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.9 | ||
| Fwd PE | 30.31 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as QS51.
The rest of the industry has a similar Price/Free Cash Flow ratio as QS51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 55.25 | ||
| EV/EBITDA | 21.82 |
4.3 Compensation for Growth
QS51's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
QS51 has an outstanding profitability rating, which may justify a higher PE ratio.
QS51's earnings are expected to grow with 19.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.26
PEG (5Y)7.58
EPS Next 2Y22.85%
EPS Next 3Y19.99%
5. Dividend
5.1 Amount
With a yearly dividend of 0.87%, QS51 is not a good candidate for dividend investing.
QS51's Dividend Yield is a higher than the industry average which is at 2.19.
Compared to an average S&P500 Dividend Yield of 2.40, QS51's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
5.2 History
The dividend of QS51 is nicely growing with an annual growth rate of 10.12%!
Dividend Growth(5Y)10.12%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
QS51 pays out 34.88% of its income as dividend. This is a sustainable payout ratio.
QS51's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.88%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
FRA:QS51 (5/27/2025, 7:00:00 PM)
116.5
+0.85 (+0.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners37.88%
Inst Owner ChangeN/A
Ins Owners32.73%
Ins Owner ChangeN/A
Market Cap18.58B
Analysts73.57
Price Target143.67 (23.32%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
Yearly Dividend0.91
Dividend Growth(5Y)10.12%
DP34.88%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.9 | ||
| Fwd PE | 30.31 | ||
| P/S | 6.96 | ||
| P/FCF | 55.25 | ||
| P/OCF | 36.07 | ||
| P/B | 8.55 | ||
| P/tB | 15.34 | ||
| EV/EBITDA | 21.82 |
EPS(TTM)2.92
EY2.51%
EPS(NY)3.84
Fwd EY3.3%
FCF(TTM)2.11
FCFY1.81%
OCF(TTM)3.23
OCFY2.77%
SpS16.73
BVpS13.63
TBVpS7.59
PEG (NY)1.26
PEG (5Y)7.58
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.73% | ||
| ROE | 19.03% | ||
| ROCE | 24.3% | ||
| ROIC | 19.95% | ||
| ROICexc | 24.14% | ||
| ROICexgc | 40.83% | ||
| OM | 25.97% | ||
| PM (TTM) | 15.51% | ||
| GM | 71.4% | ||
| FCFM | 12.61% |
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
ROICexc(3y)24.47%
ROICexc(5y)23.84%
ROICexgc(3y)42.44%
ROICexgc(5y)41.27%
ROCE(3y)23.86%
ROCE(5y)21.7%
ROICexcg growth 3Y-8.65%
ROICexcg growth 5Y-1.8%
ROICexc growth 3Y-7.31%
ROICexc growth 5Y1.25%
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.29 | ||
| Cap/Depr | 115.76% | ||
| Cap/Sales | 6.7% | ||
| Interest Coverage | 43.15 | ||
| Cash Conversion | 60.78% | ||
| Profit Quality | 81.28% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z | 9.1 |
F-Score7
WACC4.92%
ROIC/WACC4.05
Cap/Depr(3y)127.11%
Cap/Depr(5y)116.21%
Cap/Sales(3y)7.81%
Cap/Sales(5y)7.04%
Profit Quality(3y)86.54%
Profit Quality(5y)138.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.72%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-26.32%
EPS Next Y31.67%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
EPS Next 5Y19.31%
Revenue 1Y (TTM)9.98%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%8.65%
Revenue Next Year8.48%
Revenue Next 2Y9.47%
Revenue Next 3Y9.7%
Revenue Next 5Y9.77%
EBIT growth 1Y3.25%
EBIT growth 3Y6.31%
EBIT growth 5Y9.56%
EBIT Next Year31.64%
EBIT Next 3Y18.52%
EBIT Next 5Y16.77%
FCF growth 1Y0.35%
FCF growth 3Y-10.44%
FCF growth 5Y6.66%
OCF growth 1Y-4.08%
OCF growth 3Y-4.8%
OCF growth 5Y5.01%